Achillion Pharmaceuticals downgraded
December 23, 2014 at 12:51 PM EST
Robert
W. Baird downgraded Achillion Pharmaceuticals Inc. (Nasdaq: ACHN) from
an Outperform rating to a Neutral rating sending the stock price
plummeting $3.69 to $11.80.
